Molecular minimal residual disease negativity and decreased stem cell mobilization potential predict excellent outcome after autologous transplant in NPM1 mutant acute myeloid leukemia.

Authors :: de Benito AS
Jeker B
Gfeller E
Porret N
Banz Y
Novak U
Bacher U
Pabst T
Source :: Haematologica [Haematologica] 2020 Jan; Vol. 105 (1), pp. e9-e12. Date of Electronic Publication: 2019 May 23.
Publication Year :: 2020

Subjects :: Autografts
Humans
Mutation
Neoplasm, Residual
Nuclear Proteins genetics
Nucleophosmin
Hematopoietic Stem Cell Mobilization
Leukemia, Myeloid, Acute genetics
Leukemia, Myeloid, Acute therapy

Full Text Access

Tools